Isoprenaline Chlorhydrate Tillomed

Isoprenaline, the active ingredient in Isoprenaline Chlorhydrate Tillomed, is a non‑selective beta‑adrenergic agonist presented as a strength/form for intravenous use. It is used to raise heart rate and contractility in bradycardia and to relax bronchial smooth muscle in asthma. GNH USA supplies Isoprenaline Chlorhydrate Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoprenaline acts on the cardiac and respiratory systems to correct rhythm disturbances and relieve bronchospasm. - Bradycardia: increases heart rate and improves cardiac output. - Heart block: restores atrioventricular conduction and stabilises rhythm. - Asthma: produces bronchodilation that eases bronchospasm and improves airflow.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Tachycardia - Palpitations - Tremor - Headache - Nausea - Flushing

Serious or Rare Side Effects: - Life‑threatening arrhythmias - Myocardial ischemia - Severe hypotension - Pulmonary edema - Anaphylactic or severe allergic reactions - Exacerbation of bronchospasm

Careful assessment and monitoring are required before and during therapy. - Cardiac monitoring: observe heart rate, rhythm and blood pressure continuously. - Ischemic heart disease: avoid or use only with specialist supervision due to risk of angina. - Hypertension: monitor closely as beta‑2 stimulation may increase systolic pressure. - Renal or hepatic impairment: adjust dose cautiously and monitor drug levels if available. - Pheochromocytoma: contraindicated because of potential hypertensive crisis. - Store at room temperature: keep in original container, protect from moisture and light.

Isoprenaline may interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Beta‑blockers: antagonise therapeutic effects and may precipitate severe bradycardia. - Calcium channel blockers: additive cardiac effects can lead to arrhythmias. - Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive episodes.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypotensive response. - Other antihypertensives: require blood pressure monitoring. - General anaesthetics: may enhance cardiovascular depression; adjust dosing as needed.